A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension

Clinical trial NCT07613216 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07613216
Sponsor: Cosmos Rx, Inc
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Idiopathic Pulmonary Fibrosis (IPF)Sarcoidosis Lung Pulmonary Hypertension Usual Interstitial Pneumonia

Start date: 2026-07-01
Primary completion: 2027-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.